| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | BPH GLOBAL LTD: Becoming a substantial holder | - | ASX | ||
| Mo | BPH GLOBAL LTD: Seaweed Trading Results - Direct China Exports Commence | - | ASX | ||
| 08.07. | BPH GLOBAL LTD: BPH Global commences direct seaweed exports to China | - | ASX | ||
| 22.06. | BPH GLOBAL LTD: Final Director's Interest Notice | - | ASX | ||
| 22.06. | BPH GLOBAL LTD: Resignation / Appointment of Chairman | - | ASX | ||
| BPH GLOBAL Aktie jetzt für 0€ handeln | |||||
| 12.06. | BPH GLOBAL LTD: Investor Presentation | - | ASX | ||
| 28.05. | BPH GLOBAL LTD: Strong seaweed trading results A$3.33M over first 12 months | - | ASX | ||
| 27.05. | BPH GLOBAL LTD: Becoming a substantial holder | - | ASX | ||
| 12.05. | BPH GLOBAL LTD: Agreement to Develop Powdered Green Seaweed Kefir Additive | - | ASX | ||
| 07.05. | BPH GLOBAL LTD: Update to Quarterly Activities Report | - | ASX | ||
| 07.05. | BPH GLOBAL LTD: Testing Agreement Executed for Project Giddy-Up | - | ASX | ||
| 06.05. | BPH GLOBAL LTD: Binding MoU to Progress Development of Makassar Coastal Site | - | ASX | ||
| 30.04. | BPH GLOBAL LTD: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 28.04. | BPH GLOBAL LTD: Trading Results Rebound as Seasonal Conditions Improve | - | ASX | ||
| 27.04. | BPH GLOBAL LTD: Appointment of Chief Scientific Officer | - | ASX | ||
| 24.04. | BPH GLOBAL LTD: Sale of China Birds Nest Business | - | ASX | ||
| 23.04. | BPH GLOBAL LTD: Development of Seaweed-based anti-aging supplement | - | ASX | ||
| 22.04. | BPH GLOBAL LTD: BPH Global Secures Coastal Site for Seaweed Cultivation | - | ASX | ||
| 20.04. | BPH GLOBAL LTD: BPH Global Launches New Investor Hub | - | ASX | ||
| 16.04. | BPH GLOBAL LTD: Notification of cessation of securities - BP8 | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PAION | 0,061 | -6,92 % | XFRA MISTRADE ANTRAG IN ISIN DE000A3E5EG5 WURDE STATTGEGEBEN | Dem Mistrade-Antrag wurde stattgegeben. Folgende Geschaefte in der ISIN DE000A3E5EG5, Wertpapier-Name: PAION AG INH O.N., wurden aufgehoben:ISIN Datum Zeit Volumen PreisDE000A3E5EG5 02.02.2026 08:13:40 300 0... ► Artikel lesen | |
| EPIGENOMICS | 0,950 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.07.2026 | Das Instrument PMRA ES0169501022 PHARMA MAR S.A. EO -,60 EQUITY wird cum Kapitalmassnahme gehandelt am 07.07.2026 und ex Kapitalmassnahme am 08.07.2026 The instrument PMRA ES0169501022 PHARMA MAR S.A.... ► Artikel lesen | |
| CO.DON | 0,014 | 0,00 % | EQS-AFR: CO.DON AG i.l.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: CO.DON AG i.l.
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
CO.DON AG i.l.: Vorabbekanntmachung über die... ► Artikel lesen | |
| SIRONA BIOCHEM | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 24.04.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.04.2026.ISIN NameCA46658Y1034 J2... ► Artikel lesen | |
| NUREXONE BIOLOGIC | 0,294 | -7,84 % | NurExone: Brücke zwischen Exosomenforschung und Wellnessmarkt | ||
| REPLENISH NUTRIENTS | 0,093 | -2,11 % | Replenish Nutrients Holding Corp: Replenish completes plant commissioning at Beiseker | ||
| NEOVACS | 0,861 | -21,77 % | XFRA NEW INSTRUMENTS AVAILABLE ON 23.06.2026 | The following instruments on XETRA do have their first trading 23.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.06.2026
Aktien
1 CNE100007CW0 Shenzen Xunce Technology... ► Artikel lesen | |
| NANOSPHERE HEALTH SCIENCES | 0,008 | -46,43 % | Nanosphere Health Sciences Inc (2): Nanosphere Health adopts semi-annual reporting | ||
| GENETIC TECHNOLOGIES | 0,034 | -100,00 % | GENETIC TECHNOLOGIES LIMITED: Long Term Suspended Entities | ||
| TRIVARX | - | - | TRIVARX LTD: Stabl-Im clinical trial supply milestone achieved | ||
| RECCE PHARMACEUTICALS | 0,206 | 0,00 % | RECCE PHARMACEUTICALS LTD: Vietnamese Patent Granted for RECCE Anti-Infectives | ||
| CRISM THERAPEUTICS | - | - | CRISM Therapeutics - Holding(s) in Company | ||
| THX PHARMA | 3,645 | 0,00 % | THX PHARMA: THX Pharma Reports Cash Position as of June 30, 2026 | Lyon, France - July 9, 2026 - 6:00 p.m. CET - THX Pharma (Theranexus), an innovative biopharmaceutical company focused on the treatment of rare neurological diseases, today announced its cash position... ► Artikel lesen | |
| PYC THERAPEUTICS | - | - | PYC THERAPEUTICS LIMITED: Results of Meeting | ||
| PATRYS | - | - | PATRYS LIMITED: Cleansing Notice |